Is venetoclax appropriate for relapsed CLL patients?
The exciting field of imaging in multiple myeloma
Jens Hillengass et al.
Involving patients in clinical trial design: a message to academia and industry
"Sequential triple-T" therapy for CLL
Highlights from the International Symposium on Acute Leukemias (ISAL) 2017 in Munich